BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//CCMG | CCGM - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://ccmg.51-222-78-205.ygkweb.ca
X-WR-CALDESC:Events for CCMG | CCGM
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Toronto
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20250926T120000
DTEND;TZID=America/Toronto:20250926T130000
DTSTAMP:20260628T135519
CREATED:20250918T224026Z
LAST-MODIFIED:20260302T214756Z
UID:10000098-1758888000-1758891600@ccmg.51-222-78-205.ygkweb.ca
SUMMARY:Can-GARD/CCMG – The Leading Strand Series
DESCRIPTION:This series is for genetics health professionals led by the Canadian College of Medical Genetics and co-sponsored by Can-GARD. Speakers will be translation-focused researchers\, clinicians and innovators.  The series will help attendees anticipate\, access\, and apply new approaches and technologies for patient care. \nThe Can-GARD/CCMG Leading Strand Series is a self-approved group learning activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada. \nWe are pleased to share that as of the 2026/2027 season\, the Garrod Association will be providing two presentations per season. \nTo register\, click the button below or go to: https://us06web.zoom.us/webinar/register/WN_e2yO6xnsSK2v70BLslqwjA  \n \n  \n  \n  \n2025-2026 Leading Strand from 12:00pm – 1:00pm ET on:\nFriday September 26\, 2025 \nNeurotransmitter Disorders – Updates \nThis session will provide an introduction to monoamine and amino acid neurotransmitter disorders\, and updates on novel diagnoses and therapies. \nLearning Objectives: \n\nAssess patients presenting with symptoms of neurotransmitter disorders.\nDiagnose and treat patients with monoamine and amino acid neurotransmitter deficiencies.\n\nSpeaker: Dr. Gabriella Horvath \nBio: Dr. Gabriella Horvath is a Biochemical Geneticist\, Clinical Professor at the University of British Columbia\, Department of Pediatrics\, Division of Biochemical Genetics. She works both in the Pediatric and adult metabolic clinics\, and has special interest in neurometabolic disorders. \nFriday October 24\, 2025 \nFriday November 28\, 2025 \nFriday December 12\, 2025 at 12:30pm – 1:30pm ET\nFriday January 30\, 2026\nFriday February 27\, 2026\nFriday March 27\, 2026 \nFriday April 24\, 2026\nFriday May 29\, 2026\nFriday June 26\, 2026
URL:https://ccmg.51-222-78-205.ygkweb.ca/event/can-gard-ccmg-the-leading-strand-series-4-2/
ORGANIZER;CN="CCMG | CCGM":MAILTO:info@ccmg-ccgm.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20251005T100000
DTEND;TZID=America/Toronto:20251008T170000
DTSTAMP:20260628T135519
CREATED:20240816T180417Z
LAST-MODIFIED:20240816T180417Z
UID:10000042-1759658400-1759942800@ccmg.51-222-78-205.ygkweb.ca
SUMMARY:CAGC & CCMG Joint Annual Scientific Meeting
DESCRIPTION:Our next in-person event will be the CAGC & CCMG Joint Annual Scientific Meeting October 5-8\, 2025 at the Banff Centre for the Arts and Creativity in Banff\, Alberta. \nSave the date and more information coming soon! \nVisit the website: https://cagcccmg.com/
URL:https://ccmg.51-222-78-205.ygkweb.ca/event/cagc-ccmg-joint-annual-scientific-meeting/
LOCATION:Banff Centre for Arts and Creativity\, Banff\, AB\, 107 Tunnel Mountain Dr\, Banff\, Alberta\, T1L 1H5\, Canada
ORGANIZER;CN="CCMG | CCGM":MAILTO:info@ccmg-ccgm.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20251017T110000
DTEND;TZID=America/Toronto:20251017T120000
DTSTAMP:20260628T135519
CREATED:20251010T145218Z
LAST-MODIFIED:20251010T145857Z
UID:10000112-1760698800-1760702400@ccmg.51-222-78-205.ygkweb.ca
SUMMARY:TeleGraf
DESCRIPTION:About this series – Telehealth for Genetics Residents and Fellows. A monthly teaching session brought to you by the members of the RCPSC Specialty Committee in Medical Genetics. \nTo register\, click the button below or go to https://us06web.zoom.us/webinar/register/WN_2LAO5jlHSQ-WA_xonc9ouA. \n \n  \n  \n  \n  \n2025-2026 TeleGraf from 11:00am – 12:00pm ET on:\nFriday\, October 17\, 2025\nVascular Anomalies: The Fast and Furious (and The Slow and Benign) \nIn this session\, we will review the classification of vascular anomalies\, comparing the different types of vascular tumours and malformations\, and reflect on our role as geneticists in their assessment and management. Targeted gene-specific medications are becoming standard of care\, and we will review current and emerging therapies in this space. \nLearning Objectives: \n\nOutline how to classify vascular anomalies.\nDistinguish sporadic versus syndromic vascular anomalies.\nDevelop an approach to the genetic work-up of vascular anomalies.\nUnderstand emerging therapies for the treatment of vascular anomalies.\n\nSpeaker: Dr. Alison Castle \nBio: Dr. Alison Castle is a clinical geneticist at the Provincial Medical Genetics Program in Vancouver\, and a clinical assistant professor in the Department of Genetics at the University of British Columbia. Her clinical interests include general genetics\, connective tissue disorders and vascular anomalies. When not praticing medicine or teaching residents\, medical students\, genetic counselling students or midwives\, she can usually be found in the mountains. \n  \nFriday\, November 21\, 2025\nFriday\, January 16\, 2026\nFriday\, February 20\, 2026\nFriday\, March 20\, 2026 – Tentative\nFriday\, April 17\, 2026\nFriday\, May 15\, 2026\nFriday\, June 19\, 2026
URL:https://ccmg.51-222-78-205.ygkweb.ca/event/telegraf-4-2/
ORGANIZER;CN="CCMG | CCGM":MAILTO:info@ccmg-ccgm.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20251024T120000
DTEND;TZID=America/Toronto:20251024T130000
DTSTAMP:20260628T135519
CREATED:20251019T145207Z
LAST-MODIFIED:20260302T214810Z
UID:10000099-1761307200-1761310800@ccmg.51-222-78-205.ygkweb.ca
SUMMARY:Can-GARD/CCMG – The Leading Strand Series
DESCRIPTION:This series is for genetics health professionals led by the Canadian College of Medical Genetics and co-sponsored by Can-GARD. Speakers will be translation-focused researchers\, clinicians and innovators.  The series will help attendees anticipate\, access\, and apply new approaches and technologies for patient care. \nThe Can-GARD/CCMG Leading Strand Series is a self-approved group learning activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada. \nWe are pleased to share that as of the 2026/2027 season\, the Garrod Association will be providing 2 presentations per season. \nTo register\, click the button below or go to: https://us06web.zoom.us/webinar/register/WN_e2yO6xnsSK2v70BLslqwjA  \n \n  \n  \n  \n2025-2026 Leading Strand from 12:00pm – 1:00pm ET on:\nFriday October 24\, 2025 \nRewriting the Code: Genetics\, Bioessentialism\, and the Future of Intersex Care \nThis seminar invites genetic health professionals to critically examine how concepts of sex\, gender\, and variations in sex characteristics (VSCs) have evolved within medicine and society. We will trace the historical development of intersex and VSC healthcare\, define bioessentialism\, and discuss how it continues to shape policy and clinical language. The session will consider how these narratives influence current practice\, including the use of genomic tools such as cfDNA\, and explore the constructive role genetics can play in supporting individuals and their families. Participants will reflect on strategies for delivering genetic information with clarity and intention – considering pacing\, family dynamics\, trauma-informed approaches\, and communication about tumor risk – to ultimately advance empowered\, family-centered care. \nLearning Objectives: \n\nDescribe the distinctions and intersections between sex\, gender\, and intersex variations/variations in sex characteristics (VSC)\, with attention to their clinical and sociocultural relevance in genetics.\nExamine the legacy of bioessentialism in shaping historical and contemporary practices within genetic medicine.\nExplore strategies for ethically grounded\, family-centered genetic care\, including nuanced communication of risk\, pacing of information\, and language that supports empowerment and informed decision-making.\n\nSpeaker: Kayla Horowitz \nBio: Kayla Horowitz\, MSc\, CGC (she/her/elle) is a certified genetic counsellor at the Cliniques Universitaires Saint-Luc in Brussels\, Belgium\, where she holds specialized clinics in cancer genetics\, reproductive genetics\, neurogenetics\, and variations of sex characteristics (VSC). A 2022 graduate of the McGill University Masters of Genetic Counselling program\, she has published works amplifying the voices of individuals with VSC and their families\, aiming to drive meaningful change in clinical practice. Her work bridges intersex community advocacy and medical collaboration\, focusing on deconstructing binary views of sex and gender and promoting safe\, inclusive healthcare environments. \nFriday November 28\, 2025 \nFriday December 12\, 2025 at 12:30pm – 1:30pm ET\nFriday January 30\, 2026\nFriday February 27\, 2026\nFriday March 27\, 2026 \nFriday April 24\, 2026\nFriday May 29\, 2026\nFriday June 26\, 2026
URL:https://ccmg.51-222-78-205.ygkweb.ca/event/can-gard-ccmg-the-leading-strand-series-4-3/
ORGANIZER;CN="CCMG | CCGM":MAILTO:info@ccmg-ccgm.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20251121T110000
DTEND;TZID=America/Toronto:20251121T120000
DTSTAMP:20260628T135519
CREATED:20251118T173535Z
LAST-MODIFIED:20251118T174219Z
UID:10000113-1763722800-1763726400@ccmg.51-222-78-205.ygkweb.ca
SUMMARY:TeleGraf
DESCRIPTION:About this series – Telehealth for Genetics Residents and Fellows. A monthly teaching session brought to you by the members of the RCPSC Specialty Committee in Medical Genetics. \nTo register\, click the button below or go to https://us06web.zoom.us/webinar/register/WN_2LAO5jlHSQ-WA_xonc9ouA. \n \n  \n  \n  \n  \n2025-2026 TeleGraf from 11:00am – 12:00pm ET on:\nFriday\, November 21\, 2025\nOverview of Prenatal Risk Determination \nIn this presentation\, the speaker will provide a high level review of the considerations that go into risk assessment for a fetus (prenatal screening)\, concepts of testing options at each level. \nLearning objectives: \n\nIdentify controversies around testing in each area.\nCompare different screening targets in pregnancy.\nDescribe the use of different prenatal screening tests in pregnancy.\nRecognize populations at increased risk of genetic disorders.\n\nSpeaker: Dr. Joanna Lazier \nDr. Joanna Lazier is a Clinical Geneticist at the Children’s Hospital of Eastern Ontario in Ottawa. She completed her training in Calgary\, and then worked in Edmonton where she led the creation of their prenatal genetics clinic. She has a longstanding clinical interest in prenatal genetics\, and recently co-chaired the CCMG working group for reproductive carrier screening. She is the current co-chair of the CCMG working group for prenatal cell free DNA screening. \nFriday\, January 16\, 2026\nFriday\, February 20\, 2026\nFriday\, March 20\, 2026 – Tentative\nFriday\, April 17\, 2026\nFriday\, May 15\, 2026\nFriday\, June 19\, 2026
URL:https://ccmg.51-222-78-205.ygkweb.ca/event/telegraf-4-3/
ORGANIZER;CN="CCMG | CCGM":MAILTO:info@ccmg-ccgm.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20251128T120000
DTEND;TZID=America/Toronto:20251128T130000
DTSTAMP:20260628T135519
CREATED:20251120T213458Z
LAST-MODIFIED:20260302T214833Z
UID:10000100-1764331200-1764334800@ccmg.51-222-78-205.ygkweb.ca
SUMMARY:Can-GARD/CCMG – The Leading Strand Series
DESCRIPTION:This series is for genetics health professionals led by the Canadian College of Medical Genetics and co-sponsored by Can-GARD. Speakers will be translation-focused researchers\, clinicians and innovators.  The series will help attendees anticipate\, access\, and apply new approaches and technologies for patient care. \nThe Can-GARD/CCMG Leading Strand Series is a self-approved group learning activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada. \nWe are pleased to share that as of the 2026/2027 season\, the Garrod Association will be providing two presentations per season. \nTo register\, click the button below or go to: https://us06web.zoom.us/webinar/register/WN_e2yO6xnsSK2v70BLslqwjA  \n \n  \n  \n  \n2025-2026 Leading Strand from 12:00pm – 1:00pm ET on:\nFriday November 28\, 2025 \nCreatine Deficiency Syndromes \nThis session will introduce the audience to the physiological role of creatine and to the proteins involved in creatine homeostasis. This session will then exemplify the consequences of genetic defects in creatine metabolism genes\, how to diagnose the conditions and how to treat them. In the second part\, the session will take the audience on a journey that starts at pathophysiological considerations leading to single-patient treatment attempts\, that continues to bed-to-bench clinical research\, and that finally opens the path to fundamental basic research. \nLearning Objectives: \n\nSummarize Creatine Deficiency Syndromes.\nDefend the benefit of newborn screening for GAMT deficiency.\nDescribe creatine metabolism and its function.\nPractice the path of clinical observation and (patho)physiological consideration to translational research and discovery.\n\nSpeaker: Dr. Andreas Schultze  \nDr. Andreas Schulze is Professor of Paediatrics and Biochemistry at the University of Toronto. He is Medical Director of the Newborn Screening Program and Senior Associate Scientist in the Research Institute at the Hospital for Sick Children. He is board certified in Physiological Biochemistry and in Pediatrics. \nAfter graduating from Med School with medical diploma and doctorate at the University of Leipzig\, Dr. Schulze completed a PhD program in Physiological Biochemistry with summa cum laude. At Ruprecht-Karls University Heidelberg\, he received training in Pediatrics\, wrote a Professorial Thesis (Habilitation)\, and received the Venia Legendi. \nSince 2007\, Dr. Schulze has worked as Clinician Scientist at SickKids in Toronto and established his own research program at the SickKids Research Institute. His research encompasses creatine disorders and creatine homeostasis including arginine-\, ornithine-\, and guanidino compound metabolism\, and small molecule drug discovery. \nFriday December 12\, 2025 at 12:30pm – 1:30pm ET\nFriday January 30\, 2026\nFriday February 27\, 2026\nFriday March 27\, 2026 \nFriday April 24\, 2026\nFriday May 29\, 2026\nFriday June 26\, 2026
URL:https://ccmg.51-222-78-205.ygkweb.ca/event/can-gard-ccmg-the-leading-strand-series-4-4/
ORGANIZER;CN="CCMG | CCGM":MAILTO:info@ccmg-ccgm.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20251212T123000
DTEND;TZID=America/Toronto:20251212T133000
DTSTAMP:20260628T135519
CREATED:20251204T153944Z
LAST-MODIFIED:20260302T214857Z
UID:10000109-1765542600-1765546200@ccmg.51-222-78-205.ygkweb.ca
SUMMARY:Can-GARD/CCMG – The Leading Strand Series
DESCRIPTION:This series is for genetics health professionals led by the Canadian College of Medical Genetics and co-sponsored by Can-GARD. Speakers will be translation-focused researchers\, clinicians and innovators.  The series will help attendees anticipate\, access\, and apply new approaches and technologies for patient care. \nThe Can-GARD/CCMG Leading Strand Series is a self-approved group learning activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada. \nWe are pleased to share that as of the 2026/2027 season\, the Garrod Association will be providing two presentations per season. \nTo register\, click the button below or go to: https://us06web.zoom.us/webinar/register/WN_e2yO6xnsSK2v70BLslqwjA  \n \n  \n  \n  \n2025-2026 Leading Strand Series:\nFriday December 12\, 2025 at 12:30pm – 1:30pm ET*\n*Please note the later time of 12:30pm ET. \nThinkRare: Harnessing AI for the Early Identification of Patients with Undiagnosed Rare Genetic Diseases \nImproving the identification and diagnosis of rare genetic diseases (RGD) is recognized as a global challenge\, as patients often face a long “diagnostic odyssey” due to limited physician awareness and delayed referrals for genetic testing. In response to the Global Commission’s call to leverage technology\, we developed an AI-driven\, rule-based algorithm to search electronic medical records and flag potential undiagnosed RGD patients for referral to genetics. By validating results through medical record review and tracking subsequent diagnoses\, this approach aims to shorten diagnostic delays\, enhance patient care\, and improve outcomes for individuals and families affected by RGDs. \nLearning Objectives: \n\nDescribe AI approaches to identify undiagnosed rare genetic disease patients in electronic health records.\nDiscuss lessons learned through development of the ThinkRare algorithm at CHEO.\nExamine the potential impact of ThinkRare on Genetics and Non-Genetics clinicians.\n\nSpeaker: Dr. Kym Boycott \nKym Boycott is a Professor of Pediatrics at the University of Ottawa in Canada\, where she is a Clinical Geneticist at the Children’s Hospital of Eastern Ontario (CHEO)\, Chair of the Department of Genetics\, a Senior Scientist at the CHEO Research Institute\, and holds a Tier 1 Canada Research Chair in Rare Disease Precision Health. She leads the national Care4Rare Canada Consortium\, Rare Disease Models and Mechanisms Network\, and the All for One Precision Health Initiative\, integrating genomic\, other –omics\, data sharing\, and model systems to improve our understanding of rare disease. \nFriday January 30\, 2026\nFriday February 27\, 2026\nFriday March 27\, 2026 \nFriday April 24\, 2026\nFriday May 29\, 2026\nFriday June 26\, 2026
URL:https://ccmg.51-222-78-205.ygkweb.ca/event/can-gard-ccmg-the-leading-strand-series-4-5/
ORGANIZER;CN="CCMG | CCGM":MAILTO:info@ccmg-ccgm.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20260116T110000
DTEND;TZID=America/Toronto:20260116T120000
DTSTAMP:20260628T135519
CREATED:20260108T171407Z
LAST-MODIFIED:20260108T174653Z
UID:10000115-1768561200-1768564800@ccmg.51-222-78-205.ygkweb.ca
SUMMARY:TeleGraf
DESCRIPTION:About this series – Telehealth for Genetics Residents and Fellows. A monthly teaching session brought to you by the members of the RCPSC Specialty Committee in Medical Genetics. \nTo register\, click the button below or go to https://us06web.zoom.us/webinar/register/WN_2LAO5jlHSQ-WA_xonc9ouA. \n \n  \n  \n  \n  \n2025-2026 TeleGraf from 11:00am – 12:00pm ET on:\nFriday\, January 16\, 2026\nReview and Update of the Ehlers-danlos Syndromes (EDS) and the Hypermobility Spectrum Disorders (HSD) \nWe will review the last classification of Ehlers-Danlos syndromes (EDS) by the International Consortium on EDS (2017)\, describing 13 types (a fourteenth added since) and their genetic etiology. The diagnostic criteria of the most frequent type\, hypermobile Ehlers-Danlos syndrome (hEDS)\, and of the hypermobility spectrum disorders (HSD) will be presented. hEDS is an exception in that it clusters in families in a dominant fashion\, but no known single gene is associated. We will review the recent genomic studies of this complex multisystemic and multifactorial disorder and possible overlapping mechanisms with HSD. Finally\, we will review the numerous co-existing conditions with EDS\, particularly with hEDS\, demonstrating the multisystemic and variable expression of this disorder. \nLearning Objectives: \n\nIdentify the 14 types of Ehlers-Danlos syndromes (EDS) and their genetic etiology.\nDiagnose the frequent type\, Ehlers-Danlos hypermobile type (hEDS)\, and the hypermobility spectrum disorders (HSD).\nRecognize the various conditions co-existing with EDS demonstrating its multisystemic nature and variable expression.\n\nSpeaker: Dr. Gail Ouellette \nGail Ouellette has a PhD. in molecular genetics (Université de Montréal) and MSc. in genetic counselling (McGill University). She was the founding-president of the Regroupement québécois des maladies orphelines\, RQMO. She established the RQMO’s iRARE Centre and its EDS Support Centre. She has recently founded the Canadian iRARE Centres. Gail Ouellette is a member of the Board of Directors of the Groupe d’étude et de recherche sur le syndrome d’Ehlers-Danlos (GERSED\, France) and is a medical advisor for the EDS Canada Foundation. She has obtained training on EDS through the EDS Canada Foundation’s annual education conferences and through the EDS Society’s international symposiums and ECHO programs for health professionals\, including the continuing ECHO Genetics & Genomics program. She has taught courses on the molecular and genetic aspects of EDS as part of the University Certificate on Ehlers-Danlos syndrome offered by the Faculty of Medicine of Université Paris-Est (Créteil). \nFriday\, February 20\, 2026\nFriday\, March 20\, 2026 – Tentative\nFriday\, April 17\, 2026\nFriday\, May 15\, 2026\nFriday\, June 19\, 2026
URL:https://ccmg.51-222-78-205.ygkweb.ca/event/telegraf-4-4/
ORGANIZER;CN="CCMG | CCGM":MAILTO:info@ccmg-ccgm.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20260130T120000
DTEND;TZID=America/Toronto:20260130T130000
DTSTAMP:20260628T135519
CREATED:20260108T215953Z
LAST-MODIFIED:20260302T215104Z
UID:10000110-1769774400-1769778000@ccmg.51-222-78-205.ygkweb.ca
SUMMARY:Can-GARD/CCMG – The Leading Strand Series
DESCRIPTION:This series is for genetics health professionals led by the Canadian College of Medical Genetics and co-sponsored by Can-GARD. Speakers will be translation-focused researchers\, clinicians and innovators.  The series will help attendees anticipate\, access\, and apply new approaches and technologies for patient care. \nThe Can-GARD/CCMG Leading Strand Series is a self-approved group learning activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada. \nWe are pleased to share that as of the 2026/2027 season\, the Garrod Association will be providing two presentations per season. \nTo register\, click the button below or go to: https://us06web.zoom.us/webinar/register/WN_e2yO6xnsSK2v70BLslqwjA  \n \n  \n  \n  \n2025-2026 Leading Strand from 12:00pm – 1:00pm ET on:\nFriday January 30\, 2026\n\nCanadian Guidelines for the Management of Spinal Bulbar Muscular Atrophy \nReview the high prevalence of SBMA in Indigenous people in Canada\, and the need for increased awareness. Discuss the process and content of the recently published Canadian SBMA guideline. \nLearning Objectives: \n\nDiscuss the need for the recently published Canadian guidelines.\nRecognize the significance of Spinal Bulbar Muscular Atrophy for Indigenous people in Canada.\nUnderstand what the new SBMA Guidelines mean for health care professionals.\nDiscuss ongoing endeavors to promote awareness of SBMA guidelines.\n\nSpeaker: Dr. Kerri Schellenberg \nDr. Kerri Schellenberg\, MD\, FRCPC\, MMedEd is a Neuromuscular Neurologist and Associate Professor at the University of Saskatchewan. She is the Medical Director of the ALS/MND clinic and the Medical Director of the Royal University Hospital EMG lab. She serves as Competency Committee Chair for the neurology program. Her research primarily focuses on motor neuron diseases (ALS\, SBMA\, and SMA)\, and includes publications in clinical aspects of neuromuscular disease. She has served as local PI for international treatment trials in ALS\, local PI for the Canadian Neuromuscular Disease registry\, contributed to Canadian ALS Best Practice Recommendations\, and has ongoing grants and projects with local and national research partners to further understanding of neuromuscular disease. \nShe completed her medical studies at the University of Saskatchewan\, a Neurology residency at the University of Alberta\, followed by a Neuromuscular fellowship at Duke University in North Carolina. Dr. Schellenberg was the recipient of the Betty Norman Research Fellowship Award from the ALS Society of Canada to pursue an ALS fellowship at the University of Alberta. She has a Masters of Medical Education from the University of Dundee. \nFriday February 27\, 2026\nFriday March 27\, 2026 \nFriday April 24\, 2026\nFriday May 29\, 2026\nFriday June 26\, 2026
URL:https://ccmg.51-222-78-205.ygkweb.ca/event/can-gard-ccmg-the-leading-strand-series-4-6/
ORGANIZER;CN="CCMG | CCGM":MAILTO:info@ccmg-ccgm.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20260220T110000
DTEND;TZID=America/Toronto:20260220T120000
DTSTAMP:20260628T135519
CREATED:20260211T215529Z
LAST-MODIFIED:20260212T203441Z
UID:10000116-1771585200-1771588800@ccmg.51-222-78-205.ygkweb.ca
SUMMARY:TeleGraf
DESCRIPTION:About this series – Telehealth for Genetics Residents and Fellows. A monthly teaching session brought to you by the members of the RCPSC Specialty Committee in Medical Genetics. \nTo register\, click the button below or go to https://us06web.zoom.us/webinar/register/WN_2LAO5jlHSQ-WA_xonc9ouA. \n \n  \n  \n  \n  \n2025-2026 TeleGraf from 11:00am – 12:00pm ET on:\nFriday\, February 20\, 2026\nHiding in Plain Sight – What we have learned about and from ReNU Syndrome in 18 Months \nOver the course of this presentation we will reflect on the remarkable progress made in the understanding of the ReNU syndrome since it was first identified about 18 months. We will also provide perspectives from clinicians\, researchers and families on some of the major priorities moving forward. \nLearning Objectives: \n\nIdentify classes of genetic variants not well detected by routine clinical testing.\nDescribe the clinical features of ReNU syndrome and related disorders.\nReflect on the importance of patients and families as partners with clinicians and scientists in identifying priorities in rare disease care and research.\n\nSpeakers: Dr. Micheil Innes & Lindsay Pearse \n \nDr. Micheil Innes is a Professor of Pediatrics and Medical Genetics\, Cumming School of Medicine\, University of Calgary. His clinical interests include dysmorphology\, neurogenetics and hereditary endocrine disorders and his academic program focuses on gene discovery\, syndrome delineation and translation of novel genetic technologies to the clinic. He is a past chair of the Specialty Committee of Medical Genetics and Genomics at the Royal College\, and was a previous (and current acting) program director of the Medical Genetics and Genomics residency training program at the University of Calgary. \n  \n \nLindsay Pearse is a co-founder of ReNU Syndrome United and serves as the Vice President of the Board. She resides in Northern Virginia with her husband and three sons\, ages 9\, 4\, and 2. Her oldest son\, Lars\, was diagnosed with ReNU syndrome in March 2024. Lindsay is a passionate disability rights advocate and has served as a gubernatorial appointee on the Virginia Developmental Disabilities Council for the past 6 years. Lindsay has 20 years of experience in the public and nonprofit sectors\, and most recently spent 10+ years overseeing strategy and operations at the United Nations Foundation. Lindsay is immensely grateful to finally have our community of ReNU warriors and is honored to be involved in advancing the mission of ReNU Syndrome United. \n\n\n\nFriday\, March 20\, 2026 – Tentative\nFriday\, April 17\, 2026\nFriday\, May 15\, 2026\nFriday\, June 19\, 2026
URL:https://ccmg.51-222-78-205.ygkweb.ca/event/telegraf-4-5/
ORGANIZER;CN="CCMG | CCGM":MAILTO:info@ccmg-ccgm.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20260227T120000
DTEND;TZID=America/Toronto:20260227T130000
DTSTAMP:20260628T135519
CREATED:20260219T214605Z
LAST-MODIFIED:20260302T214932Z
UID:10000124-1772193600-1772197200@ccmg.51-222-78-205.ygkweb.ca
SUMMARY:Can-GARD/CCMG – The Leading Strand Series
DESCRIPTION:This series is for genetics health professionals led by the Canadian College of Medical Genetics and co-sponsored by Can-GARD. Speakers will be translation-focused researchers\, clinicians and innovators.  The series will help attendees anticipate\, access\, and apply new approaches and technologies for patient care. \nThe Can-GARD/CCMG Leading Strand Series is a self-approved group learning activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada. \nWe are pleased to share that as of the 2026/2027 season\, the Garrod Association will be providing two presentations per season. \nTo register\, click the button below or go to: https://us06web.zoom.us/webinar/register/WN_e2yO6xnsSK2v70BLslqwjA  \n \n  \n  \n  \n2025-2026 Leading Strand from 12:00pm – 1:00pm ET on:\nFriday February 27\, 2026\nIntegrating Genomics into Pediatric Care \nThis session will provide an overview of the development of a genomics program for the care for children at Children’s Wisconsin. \nLearning Objectives: \n\nExplain the importance of integrating genomics.\nUnderstand the challenges involved.\nDescribe the process of integrating genomic information into patient care.\nAppreciate the various nuances in overall genomic medicine.\n\nSpeaker: Dr. Donald Basel \nDr. Donald Basel is a Professor of Pediatrics and Division Chief of Genetics at MCW. He serves as the Medical Director for Genetics and the Undiagnosed Center of Excellence at Children’s Wisconsin. He has been a practicing geneticist for 25 years\, 7 years in bench research developing proof of concept therapies for targeted down regulation of collagen in a osteogenesis imperfect mouse model. He has grown the genomics program at CW/MCW and implemented an integrated genomics approach to diagnosis and care for children at CW. He is the PI on several studies for inborn errors of metabolism and has a strong track record of research collaboration. He is a keen advocate for healthy kids in Wisconsin and strives to improve quality of care and equitable access to tertiary care for all.\n \nFriday March 27\, 2026 \nFriday April 24\, 2026\nFriday May 29\, 2026\nFriday June 26\, 2026
URL:https://ccmg.51-222-78-205.ygkweb.ca/event/can-gard-ccmg-the-leading-strand-series-4-7/
ORGANIZER;CN="CCMG | CCGM":MAILTO:info@ccmg-ccgm.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20260327T120000
DTEND;TZID=America/Toronto:20260327T130000
DTSTAMP:20260628T135519
CREATED:20260311T155635Z
LAST-MODIFIED:20260313T192735Z
UID:10000125-1774612800-1774616400@ccmg.51-222-78-205.ygkweb.ca
SUMMARY:Can-GARD/CCMG – The Leading Strand Series
DESCRIPTION:This series is for genetics health professionals led by the Canadian College of Medical Genetics and co-sponsored by Can-GARD. Speakers will be translation-focused researchers\, clinicians and innovators.  The series will help attendees anticipate\, access\, and apply new approaches and technologies for patient care. \nThe Can-GARD/CCMG Leading Strand Series is a self-approved group learning activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada. \nWe are pleased to share that as of the 2026/2027 season\, the Garrod Association will be providing two presentations per season. \nTo register\, click the button below or go to: https://us06web.zoom.us/webinar/register/WN_e2yO6xnsSK2v70BLslqwjA  \n \n  \n  \n  \n2025-2026 Leading Strand from 12:00pm – 1:00pm ET on:\nFriday March 27\, 2026\n\nUnderstanding Neurodevelopmental Disorders Using Human Neurons and Brain Organoids\nThis talk will highlight how human stem cell–derived neurons and brain organoids can capture patient-specific mutations and cellular phenotypes relevant to rare neurodevelopmental disorders\, providing novel potential therapeutic strategies. \nLearning Objectives: \n\nDescribe how human pluripotent stem cell can be differentiated into neurons and brain organoids.\nDiscuss how human stem cells can model patient-specific genetic mutations.\nDiscuss how to discover cellular phenotypes relevant to neurodevelopmental disorders.\n\nSpeaker: Dr. Yun Li \n \nDr. Yun Li is a neurobiologist focused on understanding human brain development and the mechanisms underlying neurodevelopmental disorders. She is a Senior Scientist at the Hospital for Sick Children and a faculty member at the University of Toronto. Dr. Li received her PhD from the University of Texas Southwestern Medical Center and completed her postdoctoral training at the Whitehead Institute and MIT. Her laboratory investigates how the human brain develops\, what distinguishes it from that of other species\, and how disorders such as autism alter its developmental trajectory and function. Her group models human brain development in vitro using pluripotent stem cell technologies\, CRISPR-mediated genome engineering\, and three-dimensional brain organoids to uncover disease mechanisms and identify therapeutic opportunities. \nFriday April 24\, 2026\nFriday May 29\, 2026\nFriday June 26\, 2026
URL:https://ccmg.51-222-78-205.ygkweb.ca/event/can-gard-ccmg-the-leading-strand-series-4-8/
ORGANIZER;CN="CCMG | CCGM":MAILTO:info@ccmg-ccgm.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20260417T110000
DTEND;TZID=America/Toronto:20260417T120000
DTSTAMP:20260628T135519
CREATED:20260402T153724Z
LAST-MODIFIED:20260409T175749Z
UID:10000118-1776423600-1776427200@ccmg.51-222-78-205.ygkweb.ca
SUMMARY:TeleGraf
DESCRIPTION:About this series – Telehealth for Genetics Residents and Fellows. A monthly teaching session brought to you by the members of the RCPSC Specialty Committee in Medical Genetics. \nTo register\, click the button below or go to https://us06web.zoom.us/webinar/register/WN_2LAO5jlHSQ-WA_xonc9ouA. \n \n  \n  \n  \n  \n2025-2026 TeleGraf from 11:00am – 12:00pm ET on:\nFriday\, April 17\, 2026\nThe Molecular Autopsy: Genetics of Sudden Death \nInsights from Forensic investigation \nLearning Objectives: \n\nRecognize the key processes in death investigation\, including the roles of various professionals involved\, from forensic pathologists to clinical geneticists.\nCritically evaluate clinicopathologic data generated at autopsy as it pertains to a clinical genetics differential diagnosis.\nIdentify and understand genetic conditions which can present with sudden death\, focusing on common cardiac\, vascular\, and metabolic conditions.\n\nSpeaker: Dr. Ariel Gershon \nDr. Ariel Gershon is a final-year resident physician in Medical Genetics and Genomics at the University of Toronto. Prior to entering genetics\, he completed several years of postgraduate training in Diagnostic and Molecular Pathology\, also at the University of Toronto. \nDr. Gershon’s clinical interest lie in the intersection of medicolegal medicine and clinical genetics. He provides care across adult and prenatal genetics\, including cardiovascular\, endocrine\, or connective tissue disorders\, and focuses on genetics in the acute and critical‑care settings. He works closely with next of kin to help clarify the causes of unexpected or premature death and to identify inherited risks that may allow for prevention in surviving family members. His clinical and research work aim to integrate genomic medicine into post‑mortem and coroner‑based investigations\, improving understanding\, care\, and preventive strategies for families and at‑risk relatives. \n\nFriday\, May 15\, 2026\nFriday\, June 19\, 2026
URL:https://ccmg.51-222-78-205.ygkweb.ca/event/telegraf-4-6/
ORGANIZER;CN="CCMG | CCGM":MAILTO:info@ccmg-ccgm.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20260424T120000
DTEND;TZID=America/Toronto:20260424T130000
DTSTAMP:20260628T135519
CREATED:20260420T143701Z
LAST-MODIFIED:20260420T143815Z
UID:10000126-1777032000-1777035600@ccmg.51-222-78-205.ygkweb.ca
SUMMARY:Can-GARD/CCMG – The Leading Strand Series
DESCRIPTION:This series is for genetics health professionals led by the Canadian College of Medical Genetics and co-sponsored by Can-GARD. Speakers will be translation-focused researchers\, clinicians and innovators.  The series will help attendees anticipate\, access\, and apply new approaches and technologies for patient care. \nThe Can-GARD/CCMG Leading Strand Series is a self-approved group learning activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada. \nWe are pleased to share that as of the 2026/2027 season\, the Garrod Association will be providing two presentations per season. \nTo register\, click the button below or go to: https://us06web.zoom.us/webinar/register/WN_e2yO6xnsSK2v70BLslqwjA  \n \n  \n  \n  \n2025-2026 Leading Strand from 12:00pm – 1:00pm ET on:\nFriday April 24\, 2026\nA New Approach to Discovering Genes Underlying Inborn Errors of Immunity \nDriven by the rapid discovery of bacterial anti-phage defense systems\, numerous parallels have emerged between prokaryotic and eukaryotic cell-autonomous innate immune systems. For example\, components of human RNA interference and gasdermin pathways have functional analogues in bacteria. These findings suggest that many additional links between prokaryotic and eukaryotic immune systems remain to be uncovered\, particularly given the recent identification of more than one hundred new bacterial defense systems\, many of which remain mechanistically uncharacterized. \nIn this talk\, I will describe how we plan to leverage such parallels to identify novel immune-related genes. Specifically\, we are developing a computational pipeline for gene discovery and functional annotation\, which we will subsequently use to identify rare\, damaging variants in large cohorts of patients with immunological and autoinflammatory disorders. Our goals are to advance our understanding of inherited immune disorders\, known as inborn errors of immunity (IEIs)\, and to improve the genetic diagnostic yield for patients with IEIs. \nLearning Objectives: \n\nRecognize that discoveries from microbial immune systems can be leveraged to advance our mechanistic understanding of human immune pathways and disease biology.\nDescribe how bacteria and bacteriophages can be utilized as experimentally tractable platforms to test hypotheses generated through structural homology-based approaches.\nSummarize a new approach to identifying and prioritizing novel genes and pathways underlying inborn errors of immunity.\n\nSpeaker: Dr. Chantel Trost  \nDr. Chantel Trost received her Ph.D. in Biology from the University of Saskatchewan\, where she studied the phylogenetics and phylogeography of ticks and tick-borne pathogens. Subsequently\, she trained as a Postdoctoral Fellow in the lab of Dr. Alan Davidson in the Department of Molecular Genetics at the University of Toronto\, where she used microbiology\, biochemistry\, molecular biology\, and bioinformatics techniques to study protein inhibitors of CRISPR-Cas systems\, known as anti-CRISPRs. \nAs a new Scientist at The Hospital for Sick Children\, Dr. Trost plans to continue studying CRISPR-Cas systems—some of which are powerful genome editing tools\, while others have the potential to be harnessed to combat antimicrobial resistance—and their inhibitors. More broadly\, she is interested in uncovering the molecular mechanisms underlying host-pathogen interactions and applying this knowledge to develop innovative biotechnology tools for both research and clinical use. \nFriday May 29\, 2026\nFriday June 26\, 2026
URL:https://ccmg.51-222-78-205.ygkweb.ca/event/can-gard-ccmg-the-leading-strand-series-4-9/
ORGANIZER;CN="CCMG | CCGM":MAILTO:info@ccmg-ccgm.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20260515T110000
DTEND;TZID=America/Toronto:20260515T120000
DTSTAMP:20260628T135519
CREATED:20250904T205739Z
LAST-MODIFIED:20260212T204405Z
UID:10000119-1778842800-1778846400@ccmg.51-222-78-205.ygkweb.ca
SUMMARY:TeleGraf
DESCRIPTION:About this series – Telehealth for Genetics Residents and Fellows. A monthly teaching session brought to you by the members of the RCPSC Specialty Committee in Medical Genetics. \nTo register\, click the button below or go to https://us06web.zoom.us/webinar/register/WN_2LAO5jlHSQ-WA_xonc9ouA. \n \n  \n  \n  \n  \n2025-2026 TeleGraf from 11:00am – 12:00pm ET on:\nFriday\, October 17\, 2025\nMore details to come. \nFriday\, November 21\, 2025\nFriday\, January 16\, 2026\nFriday\, February 20\, 2026\nFriday\, March 20\, 2026 – Tentative\nFriday\, April 17\, 2026\nFriday\, May 15\, 2026\nFriday\, June 19\, 2026
URL:https://ccmg.51-222-78-205.ygkweb.ca/%tribe_events_slug%/telegraf-4/2026-05-15/
ORGANIZER;CN="CCMG | CCGM":MAILTO:info@ccmg-ccgm.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20260529T120000
DTEND;TZID=America/Toronto:20260529T130000
DTSTAMP:20260628T135519
CREATED:20250904T204226Z
LAST-MODIFIED:20260302T215027Z
UID:10000111-1780056000-1780059600@ccmg.51-222-78-205.ygkweb.ca
SUMMARY:Can-GARD/CCMG – The Leading Strand Series
DESCRIPTION:This series is for genetics health professionals led by the Canadian College of Medical Genetics and co-sponsored by Can-GARD. Speakers will be translation-focused researchers\, clinicians and innovators.  The series will help attendees anticipate\, access\, and apply new approaches and technologies for patient care. \nThe Can-GARD/CCMG Leading Strand Series is a self-approved group learning activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada. \nWe are pleased to share that as of the 2026/2027 season\, the Garrod Association will be providing two presentations per season. \nTo register\, click the button below or go to: https://us06web.zoom.us/webinar/register/WN_e2yO6xnsSK2v70BLslqwjA  \n \n  \n  \n  \n2025-2026 Leading Strand from 12:00pm – 1:00pm ET on:\nFriday September 26\, 2025 \nFriday October 24\, 2025 \nFriday November 28\, 2025 \nFriday December 12\, 2025 at 12:30pm – 1:30pm ET\nFriday January 30\, 2026\nFriday February 27\, 2026\nFriday March 27\, 2026 \nFriday April 24\, 2026\nFriday May 29\, 2026\nFriday June 26\, 2026
URL:https://ccmg.51-222-78-205.ygkweb.ca/%tribe_events_slug%/can-gard-ccmg-the-leading-strand-series-4/2026-05-29/
ORGANIZER;CN="CCMG | CCGM":MAILTO:info@ccmg-ccgm.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20260607T120000
DTEND;TZID=America/Toronto:20260610T150000
DTSTAMP:20260628T135519
CREATED:20260312T165630Z
LAST-MODIFIED:20260312T165645Z
UID:10000129-1780833600-1781103600@ccmg.51-222-78-205.ygkweb.ca
SUMMARY:CCMG & Garrod 2026 Joint Conference
DESCRIPTION:Our next in-person event will be the CCMG & Garrod 2026 Joint Conference on June 7-10\, 2026 at the Hotel Château-Bromont in Bromont\, Quebec. \nRegistration and program can be viewed on the website. \nVisit the website: https://www.ccmg-ccgm.org/ccmg-garrod-association-2026-joint-conference/
URL:https://ccmg.51-222-78-205.ygkweb.ca/event/ccmg-garrod-2026-joint-conference/
LOCATION:Hotel Château-Bromont
CATEGORIES:Annual Scientific Meeting
ORGANIZER;CN="CCMG | CCGM":MAILTO:info@ccmg-ccgm.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20260619T110000
DTEND;TZID=America/Toronto:20260619T120000
DTSTAMP:20260628T135519
CREATED:20250904T205739Z
LAST-MODIFIED:20260212T204405Z
UID:10000120-1781866800-1781870400@ccmg.51-222-78-205.ygkweb.ca
SUMMARY:TeleGraf
DESCRIPTION:About this series – Telehealth for Genetics Residents and Fellows. A monthly teaching session brought to you by the members of the RCPSC Specialty Committee in Medical Genetics. \nTo register\, click the button below or go to https://us06web.zoom.us/webinar/register/WN_2LAO5jlHSQ-WA_xonc9ouA. \n \n  \n  \n  \n  \n2025-2026 TeleGraf from 11:00am – 12:00pm ET on:\nFriday\, October 17\, 2025\nMore details to come. \nFriday\, November 21\, 2025\nFriday\, January 16\, 2026\nFriday\, February 20\, 2026\nFriday\, March 20\, 2026 – Tentative\nFriday\, April 17\, 2026\nFriday\, May 15\, 2026\nFriday\, June 19\, 2026
URL:https://ccmg.51-222-78-205.ygkweb.ca/%tribe_events_slug%/telegraf-4/2026-06-19/
ORGANIZER;CN="CCMG | CCGM":MAILTO:info@ccmg-ccgm.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20260626T120000
DTEND;TZID=America/Toronto:20260626T130000
DTSTAMP:20260628T135519
CREATED:20250904T204226Z
LAST-MODIFIED:20260302T215027Z
UID:10000127-1782475200-1782478800@ccmg.51-222-78-205.ygkweb.ca
SUMMARY:Can-GARD/CCMG – The Leading Strand Series
DESCRIPTION:This series is for genetics health professionals led by the Canadian College of Medical Genetics and co-sponsored by Can-GARD. Speakers will be translation-focused researchers\, clinicians and innovators.  The series will help attendees anticipate\, access\, and apply new approaches and technologies for patient care. \nThe Can-GARD/CCMG Leading Strand Series is a self-approved group learning activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada. \nWe are pleased to share that as of the 2026/2027 season\, the Garrod Association will be providing two presentations per season. \nTo register\, click the button below or go to: https://us06web.zoom.us/webinar/register/WN_e2yO6xnsSK2v70BLslqwjA  \n \n  \n  \n  \n2025-2026 Leading Strand from 12:00pm – 1:00pm ET on:\nFriday September 26\, 2025 \nFriday October 24\, 2025 \nFriday November 28\, 2025 \nFriday December 12\, 2025 at 12:30pm – 1:30pm ET\nFriday January 30\, 2026\nFriday February 27\, 2026\nFriday March 27\, 2026 \nFriday April 24\, 2026\nFriday May 29\, 2026\nFriday June 26\, 2026
URL:https://ccmg.51-222-78-205.ygkweb.ca/%tribe_events_slug%/can-gard-ccmg-the-leading-strand-series-4/2026-06-26/
ORGANIZER;CN="CCMG | CCGM":MAILTO:info@ccmg-ccgm.org
END:VEVENT
END:VCALENDAR